Matrix metalloproteinase expression in breast cancer

Journal of Surgical Research

Volumn 110, Issue 2, 2003, Pages 383-392

  Bartsch, John E ^a   Staren, Edgar D ^a   Appert, Hubert E ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Breast cancer; Fibronectin; Integrin; Matrix metalloproteinase; Metastasis; Mitogen activated protein kinase; Vitronectin

Indexed keywords

ACETIC ACID DERIVATIVE; ANTIBODY; COLLAGENASE 3; CONCANAVALIN A; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 16; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NEUTROPHIL COLLAGENASE; PHORBOL 13 ACETATE 12 MYRISTATE; STROMELYSIN 2; STROMELYSIN 3; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL FREE SYSTEM; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TUMOR CELL LINE; UPREGULATION; ZYMOGRAPHY;

EID: 0038547793     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00007-6     Document Type: Article

References (38)

1. Nabeshima K., Inoue T., Shimao Y., Sameshima T. Matrix metalloproteinases in tumor invasion Role for cell migration . Pathol. Int. 52:2002;255.
2. Wang T.N., Albo D., Tyszynski G.P. Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production. Surgery. 132:2000;220.
3. Iwata H., Kobayashi S., Iwase H., Masaoka A., Fujimoto N., Okada Y. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Jpn. J. Cancer Res. 87:1996;602.
4. Garbett E.A., Reed M.W., Stephenson T.J., Brown N.J. Proteolysis in human breast cancer. Mol. Pathol. 53:2000;99.
5. Curran S., Murray G.I. Matrix metalloproteinases molecular aspects of their roles in tumour invasion and metastasis . Eur. J. Cancer. 36:2000;1621.
6. Duffy M.J., Maguire T.M., Hill A., McDermott E., O'Higgins N. Metalloproteinases Role in breast carcinogenesis, invasion and metastasis . Breast Cancer Res. 2:2000;252.
7. Bernhard E.J., Gruber S.B., Muschel R.J. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA. 91:1994;4293.
8. Benaud C., Dickson R.B., Thompson E.W. Roles of the matrix metalloproteinase in mammary gland development and cancer. Breast Cancer Res. Treat. 50:1998;97.
9. Kossakowska A.E., Huchcroft S.A., Urbanski S.J., Edwards D.R. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br. J. Cancer. 73:1996;1401.
10. Dalberg K., Eriksson E., Enberg U., Kjellman M., Backdahl M. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression Correlation with invasive growth of breast cancer . World J. Surg. 24:2000;334.
11. Hanemaaijer R., Verheijen J.H., Maguire T.M., Visser H., Toet K., McDermott E., O'Higgins N., Duffy M.J. Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int. J. Cancer. 86:2000;204.
12. Heppner K.J., Matrisian L.M., Jensen R.A., Rodgers W.H. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149:1996;273.
13. Jones J.L., Glynn P., Walker R.A. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinoma. J. Pathol. 189:1999;161.
14. Bafetti L.M., Young T.N., Itoh Y., Stack M.S. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion of melanoma cells. J. Biol. Chem. 273:1998;143.
15. Reddy K.B., Krueger J.S., Kondapaka S.B., Diglio C.A. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int. J. Cancer. 82:1999;268.
16. Yang X.Q., Staren E.D., Howard J.M., Iwamura T., Bartsch J.E., Appert H.E. Invasiveness and MMP expression in pancreatic carcinoma. J. Surg. Res. 98:2001;33.
17. Liu J.-F., Crépin M., Liu J.-M., Barritault D., Ledoux D. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem. Biophys. Res. Commun. 293:2002;1174.
18. Nikolopoulos S.N., Turner C.E. Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions. J. Biol. Chem. 276:2001;23499.
19. Schaller M.D., Hildebrand J.D., Parsons J.T. Complex formation with focal adhesion kinase A mechanism to regulate activity and subcellular localization of Src kinases . Mol. Biol. Cell. 10:1999;3489.
20. Daemi N., Thomasset N., Lissitzky J.-C., Dumortier J., Jacquier M.F., Pourreyron C., Rousselle P., Chayvialle J.A., Remy L. Anti-β4 integrin antibodies enhance migratory and invasive abilities of human colon adenocarcinoma cells and their MMP-2 expression. Int. J. Cancer. 85:2000;850.
21. Giambernardi T.A., Grant G.M., Taylor G.P., Hay R.J., Maher V.M., McCormick J.J., Klebe R.J. Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol. 16:1998;483.
22. Cassara D., Ginestra A., Dolo V., Miele M., Caruso G., Lucania G., Vittorelli M.L. Modulation of vesicle shedding in 8701 BC human breast carcinoma cells. J. Submicrosc. Cytol. Pathol. 30:1998;45.
23. Barsky S.H., Togo S., Garbisa S., Liotta L.A. Type IV collagenase immunoreactivity in invasive breast carcinoma. Lancet. 1:1983;296.
24. Polette M., Clavel C., Cockett M., Girod de Bentzmann S., Murphy G., Birembaut P. Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis. 13:1993;31.
25. Hewitt R., Dano K. Stromal cell expression of components of matrix-degrading protease systems in human cancer. Enzyme Protein. 49:1996;163.
26. Balduyck M., Zerimech F., Gouyer V., Lemaire R., Hemon B., Grard G., Thiebaut C., Lemaire V., Dacquembronne E., Duhem T., Lebrun A., Dejonghe M.J., Huet G. Specific expression of matrix metalloproteinases 1, 3, 9, and 13 associated with invasiveness of breast cancer cells. in vitro. Clin. Exp. Metastasis. 18:2000;171.
27. Lebeau A., Nerlich A.G., Sauer U., Lichtinghagen R., Lohrs U. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas. Anticancer Res. 19:1999;4257.
28. Cobb M.H., Goldsmith E.J. How MAP kinases are regulated. J. Biol. Chem. 270:1995;14843.
29. Johnson M.D., Torri J.A., Lippman M.E., Dickson R.B. Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Exp. Cell Res. 247:1999;105.
30. Ree A.H., Bjornland K., Brunner N., Johansen H.T., Pedersen K.B., Aasen A.O., Fodstad O. Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells. Clin. Exp. Metastasis. 16:1998;205.
31. Yu M., Sato H., Seiki M., Spiegel S., Thompson E.W. Elevated cyclic AMP suppresses ConA-induced MT1-MMP expression in MDA-MB-231 human breast cancer cells. Clin. Exp. Metastasis. 16:1998;185.
32. Westermarck J., Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13:1999;781.
33. Simon C., Simon M., Vucelic G., Hicks M.J., Plinkert P.K., Koitschev A., Zenner H.P. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promotor activation. Exp. Cell Res. 271:2001;344.
34. Morini M., Mottolese M., Ferrari N., Ghiorzo F., Buglioni S., Mortarini R., Noonan D.M., Natali P.G., Albini A. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int. J. Cancer. 87:2000;336.
35. Schmalfeldt B., Prechtel D., Harting K., Spathe K., Rutke S., Konik E., Fridman R., Berger U., Schmitt M., Kuhn W., Lengyel E. Increased expression of matrix metalloproteinases (mmp)-2, mmp-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin. Cancer Res. 7:2001;2396.
36. Sung V., Stubbs J.T. 3rd, Fisher L., Aaron A.D., Thompson E.W. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins. J. Cell. Physiol. 176:1998;482.
37. Larjava H., Lyons J.G., Salo T., Makela M., Koivisto L., Birkedal-Hansen H., Akiyama S.K., Yamada K.M., Heino J. Anti-integrin antibodies induce type IV collagenase expression in keratinocytes. J. Cell. Physiol. 157:1993;190.
38. Miyamoto S., Katz B.-Z., Lafrenie R.M., Yamada K.M. Fibronectin and integrins in cell adhesion, signaling, and morphogenesis. Ann. NY Acad. Sci. 1857:1998;119.